Skip to main navigation Skip to search Skip to main content

ZYDUS LIFESCIENCES : announces Phase IV DREAM-CKD trial to generate Real World Evidence of Desidustat in patients with Chronic Kidney Disease induced anemia

Press/Media

Period30 Aug 2022

Media coverage

3

Media coverage